Product
Estrace
Aliases
Estrace 0.01% Vaginal Cream
4 clinical trials
4 indications
Indication
Genitourinary Syndrome of MenopauseIndication
Vulvovaginal AtrophyIndication
Urinary Tract InfectionIndication
HypoestrogenismClinical trial
Comparison of a Novel Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause: a Non-inferiority TrialStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multi-Site Study to Evaluate Therapeutic Equivalence of Estradiol Vaginal Cream, USP, 0.01% (Prasco LLC) to Estrace® Cream (Warner Chilcott) in Treatment of Vulvar and Vaginal AtrophyStatus: Completed, Estimated PCD: 2018-03-15
Clinical trial
A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of MenopauseStatus: Completed, Estimated PCD: 2022-10-03
Clinical trial
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract InfectionsStatus: Recruiting, Estimated PCD: 2027-01-01